Mitochondrial regulator ATAD3A: a molecular determinant favoring head and neck cancer development
Oncoscience
.
2023 Apr 4:10:6-8.
doi: 10.18632/oncoscience.574.
eCollection 2023.
Author
Yong Teng
1
2
Affiliations
1
Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, School of Medicine, Atlanta, GA 30322, USA.
2
Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30322, USA.
PMID:
37077859
PMCID:
PMC10109270
DOI:
10.18632/oncoscience.574
No abstract available
Keywords:
ATAD3A; ERK1/2; anti-cancer target; cancer; mitochondria.
Grants and funding
R01 DE028351/DE/NIDCR NIH HHS/United States
R03 DE028387/DE/NIDCR NIH HHS/United States
R03 DE032084/DE/NIDCR NIH HHS/United States